0001209191-17-041458.txt : 20170622 0001209191-17-041458.hdr.sgml : 20170622 20170622183403 ACCESSION NUMBER: 0001209191-17-041458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170622 DATE AS OF CHANGE: 20170622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001481512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262908274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 401-4060 MAIL ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mathers Edward T CENTRAL INDEX KEY: 0001328625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37926 FILM NUMBER: 17926031 MAIL ADDRESS: STREET 1: C/O MEDIMMUNE, INC. STREET 2: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-20 0 0001481512 Ra Pharmaceuticals, Inc. RARX 0001328625 Mathers Edward T 2150 WOODWARD ST., STE. 100 AUSTIN TX 78744 1 0 0 0 Options to Purchase Common Stock 22.37 2017-06-20 4 A 0 15000 0.00 A 2027-06-20 Common Stock 15000 15000 D On June 20, 2017, the Reporting Person was granted an option to purchase 15,000 shares of Common Stock. The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 20, 2017 or (ii) the Issuer's annual general meeting of shareholders in 2018. /s/ Sasha Keough, Attorney-in-fact 2017-06-22